Skip to main content

Table 3 Laboratory parameters of the patient before and after 152Tb-PSMA-617 administration

From: Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer

ParametersNormal rangeUnitsPatient
BeforeAfter
Hemoglobin8.6–12.1mmol/L9.09.5
Leukocytes4.3–10Gpt/L5.95.1
Thrombocytes150–400Gpt/L194207
Urea3.0–9.2mmol/L5.24.8
Creatinine62–106μmol/L62.067.1
eGFR (MDRD)> 60mL/min/1.73m2> 60> 60
ALT< 0.83μmol/s/L0.370.27
AST< 0.85μmol/s/L0.360.27
GGT0.17–1.19μmol/s/L0.700.44
  1. eGFR (MDRD) estimated glomerular filtration rate, ALT alanine transaminase, AST aspartate transaminase, GGT gamma-glutamyl transpeptidase, Before 1 month before the PET/CT scan performed with 152Tb-PSMA-617, After at the time of the next restaging, 6 months after the 152Tb-PSMA-617 application